Kanika Kapoor, PharmD


Maximizing Patient Experience with the Addition of Chat Technology

Chat communication offers convenience and access to accurate clinical information.

Farah Khorassani, PharmD, BCPS


Multiple Sclerosis Management

Symptomatic and disease-modifying treatment options for multiple sclerosis.

Kaitlin L. Musick


Combating Advancing Cancers With CAR T-Cell Therapy

Immunotherapy methods emerged on the oncology market as adoptive cell transfers, specifically chimeric antigen receptor (CAR) T-cell therapies, with clear benefits in hematologic malignancy treatment.

Thomas M. Levay, PharmD Candidate


Case Studies (August 2016)

What should these pharmacists do?

Janet Shin Lee, PhD


Outcomes Associated With Primary and Secondary Nonadherence to Cholesterol Medications

This study evaluates the impact of primary and secondary nonadherence to cholesterol medication on low-density lipoprotein levels, emergency department visits, and hospitalizations.

Swapna Johnson, MD


Efficacy of Ezetimibe 2.5 mg With a Novel Tablet-Splitting Strategy

This prospective randomized study suggests that ezetimibe 2.5 mg, delivered as an ezetimibe/simvastatin tablet split into 4 parts, is clinically equivalent to a 10-mg dose.

Audrey Castle, PharmD


Outpatient Cancer Center Cost Evaluation of Extended Beyond-Use Dating with a Closed-System Transfer Device

There is a constant balancing act for health care systems to provide the newest and most up-to-date care for patients while being financially responsible.

Margie E. Snyder, PharmD, MPH


Implications of the CMMI Enhanced Medication Therapy Management Program for the Future of Community Pharmacy

In 2006, the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 was implemented, marking the launch of medication therapy management services under Medicare Part D.

Simone Sloan, RPh, MBA


Can Blockchain Play a Role in Revamping Health Care?

Health care costs in the US represent nearly 20% of the GDP.

Amanda Binkley, PharmD, AAHIVP


Hepatitis C Treatment

There are now 8 FDA approved medications for HCV treatment, all of which bypass the use of interferon.

Tom Rhoads


Using Technology for Patient Engagement: Are We There Yet?

New tools and platforms can help pharmacists to support patients.

Kirk McKay, Managing Editor


The 340B Drug Pricing Program: Keeping Up with Changes

Health-system pharmacists need to stay abreast of changes.

Michael A. Nameth, RPh, MBA


Commentary: Specialty Pharmacy Helps Promote Patient Adherence

Successful outcomes with specialty pharmaceuticals depend on patient adherence—pharmacists play a vital role in educating patients prior to and during therapy.

Stephanie Gurren, PharmD Candidate


States Continue to Expand Availability of Telehealth

Telehealth has become a viable niche in US health care because it lets patients and providers use technology to seek medical advice and diagnose and treat illnesses.

John S. Linehan


Conflicting State Compounding Regulations Create Barriers for FDA-Registered Outsourcing Facilities

Although the federal government has taken steps to comprehensively regulate outsourcing facilities, many states have been slow to reform their pharmacy laws.

Natalie R. Jacuzzi, MPH


Impact of Medicaid Preferred Drug List on Long-Acting Opioid Users

An opioid preferred drug list was not associated with an increase in emergency department visits or hospitalizations in a Medicaid population.

Tomoko Sugihara, MS


Defining the Teriparatide Patient: Osteoporosis Sequence of Care and Healthcare Resources

This study provides real-world evidence of a teriparatide (TPTD) patient’s characteristics, sequence of care, and healthcare resource utilization, and compares TPTD patients with non-TPTD patients.

Gilbert N. Muma, PhD


Persistence With Mirabegron Versus Tolterodine in Patients With Overactive Bladder

In a retrospective analysis of the Optum database, overactive bladder patients treated with mirabegron bladder patients persisted longer with treatment than patients treated with tolterodine, and had reduced resource utilization and costs.

Barbara J. Wilson-Relyea, PhD


Cost Outcomes of Diabetes Education in a Specialized Community Pharmacy

Diabetes management offered by an employer group in a self-funded health plan over 3 years resulted in significant cost savings and improved patient outcomes.

Jenny Bingham, PharmD, BCACP


Telepharmacy Offers Opportunity Amid Pandemic

The contributions to patient care through the incorporation of digital clinical pharmacotherapy will help legitimize the role of pharmacists in telehealth.

Daniel Merenstein, MD Professor


The Expanding Health Benefits of Prebiotics and Probiotics

A Continuing Education program, featured in the February 2018 issue of Pharmacy Times.

Rahul Shenolikar, PhD


COPD Medication Adherence and Persistence Among Managed Medicare Enrollees

The authors evaluated the significance of Medicare prescription plan choice on chronic obstructive pulmonary disease maintenance medication adherence and persistence using Optum Research Database information.

Brandon Dionne, PharmD, BCPS-AQ ID, BCIDP, AAHIVP


New Antibiotics Treat Select Resistant Infections

Cefiderocol and IV fosfomycin are exciting new options, and further clinical outcomes data will help define their roles.

Hari Rayapudi


What Makes a Good Call Center for Patient Assistance Program Success?

Effective specialty pharmacy patient assistance programs help patients access and remain adherent to high cost drugs.

Willis Chandler, SVP & President, Health Systems & Specialty Services, AmerisourceBergen


Implementing a Health-System Specialty Pharmacy

By establishing in-house specialty pharmacies, health systems can accelerate growth while offering patients innovative therapies, an enhanced experience, and clinically coordinated care that ultimately improves outcomes.

© 2023 MJH Life Sciences

All rights reserved.